Results of ANDANTE, a randomised clinical study with an anti-IL6 antibody (PF-04236921) in subjects with Crohn's disease who are antitumour necrosis factor inadequate responders

Silvio Danese, Stefan Schreiber, Séverine Vermeire et al.|Unknown|2016

Cited by 7